Celtic Biotech is developing novel candidate therapies for the treatment of solid cancers and pain in humans. Derived from specialised receptor binding proteins found in snake venom, these product candidates have the potential to increase survival, improve quality-of-life and reduce treatment costs for cancer patients.
Celtic Biotech is focusing its research on solid tumours, including non-small-cell lung cancer (NSCLC), as its initial targets. The Company's lead candidate, CB-24 (Crotoxin), has been observed to be highly toxic to various tumour cell lines in pre-clinical and early clinical studies.
Company Details
- Employees
- 4
- Address
- Dublin, Ie
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.celticbiotech.com
- Keywords
- Oncology, Crotoxin, Clinical trials, Analgesia, Cancer Research, Cancer Treatment, neurotoxins, venom proteins, crotamine, cobramine.
- HQ
- Dublin
Celtic Biotech Ltd Questions
Celtic Biotech Ltd's website is https://www.celticbiotech.com
Celtic Biotech Ltd's LinkedIn profile is https://ie.linkedin.com/company/celticbiotech
Celtic Biotech Ltd has
4 employees.
View email and phone details for 4
employees at Celtic Biotech Ltd.
Celtic Biotech Ltd's industry is
Biotechnology Research
Celtic Biotech Ltd's top competitors are
Oncoassure Ltd,
Hooke Bio Ltd.,
Avectas,
Orbsen Therapeutics Limited,
Plio Surgical,
Luminate,
Mge Group,
Symphysis Medical,
Biosimulytics,
Afimmune Ltd.
Celtic Biotech Ltd's categories are Biotechnology Research
